Conclusion: We have demonstrated here a potent T22-PE24-H6 antineoplastic effect, especially in blocking dissemination in a CXCR4+ DLBCL model without associated toxicity. The gene discussed is CXCR4; the disease is diffuse large B-cell lymphoma.